Patent · US Active

PPARγ agonists for treatment of multiple sclerosis

US9867816B2 · kind B2 · utility

4Cited by
2References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 10, 2017
Grant dateJan 16, 2018
Priority date—
Expiry dateFeb 8, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.